
“Deborah agreed to take part in a trial as she was keen to help other cancer patients in the future. "If taking part in a trial means others might be helped then I’m very happy with that."
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This trial is trying to find out if wearing an elastic sleeve (external compression) helps to stop early signs of swelling in the arm developing into lymphoedema after surgery for breast cancer.
Surgery is often the first treatment for breast cancer. If the cancer has spread to your lymph nodes, your surgeon may remove all the nodes under your arm. This is called an axillary clearance. If you have an axillary clearance, the normal fluid drainage channels of the lymphatic system may become blocked. Fluid does not drain in the normal way and the arm can become swollen. This is called .
More than half of those who have some arm swelling in the first few months after surgery will develop lymphoedema within the next 2 years. In this trial, the researchers describe lymphoedema as your swollen arm being at least 10% bigger than it was before surgery.
The standard care for early signs of arm swelling would be for your specialist to give you information about lymphoedema and to monitor you closely. They can teach you ways of reducing your risk of lymphoedema, such as positioning your arm and gentle exercises. But researchers want to see if treating this early swelling with external compression helps women more than standard care. External compression involves wearing an elastic sleeve each day and is already used to treat lymphoedema.
The aim of the trial is to see if treating early signs of arm swelling with external compression reduces the number of women who go on to develop lymphoedema.
You can enter this trial if you
You cannot enter this trial if you
The trial will recruit about 270 women in the UK. It is a randomised trial. The people taking part are put into groups by a computer. Neither you nor your doctor will be able to decide which group you are in.
Women in group 1 have standard treatment for arm swelling. This includes teaching you some exercises and how to position and massage your arm.
Women in group 2 have the same treatment, but they will also have an elastic sleeve that they will be asked to wear for at least 6 hours every day for a year. The trial team will work out the size of sleeve you need. And they will advise you about how to put the sleeve on, take it off and look after it.
You will be asked to fill out a questionnaire at the beginning of the trial and then
The questionnaire will ask how you have been feeling. This is called a quality of life study. There will also be some questions about how your swollen arm affects your daily life.
The researchers will ask your permission to take a blood sample. They may use this to study your DNA to learn more about which might cause cancer or increase the chance of having treatment side effects. If you don’t want to donate this sample for research, you don’t have to. You can still take part in the main trial.
At the beginning of the trial, a member of the trial team will measure your arm using a machine called a ‘perometer’. This is a scan using 2 infra red lights directed at your arm. It takes measurements that can show if your arm has changed in size.
Women in both groups will see the trial team
They will measure both your arms each time using the perometer. If at any time this shows your arm has increased in size by 10% or more, a specialist lymphoedema nurse will talk to you about having more treatment.
Wearing a sleeve can make your skin dry. The trial team will advise you to put moisturiser on your arm each day after removing the sleeve.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nigel Bundred
NIHR Clinical Research Network: Cancer
University of Manchester
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
“Deborah agreed to take part in a trial as she was keen to help other cancer patients in the future. "If taking part in a trial means others might be helped then I’m very happy with that."